Business
Press Release Mar 15 2023
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 11, 2023, titled "Zydus receives final approval from the USFDA for Olanzapine Orally Disintegrating Tablets USP, 5 mg, 10 mg, 15 mg, and 20 mg".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 11, 2023, titled \"Zydus receives final approval from the USFDA for Olanzapine Orally Disintegrating Tablets USP, 5 mg, 10 mg, 15 mg, and 20 mg\". View Attachment","length":389,"tagName":"div"}]